Clinical trial
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low…
NCT00104572 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00104572 |
|---|---|
| Title | Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. |
| Official title | The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypogonadism, Diabetes, Sarcopenia, Osteoporosis, Depression |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Androgel (Testosterone Gel), Anastrozole (Aromatase Inhibitor), Placebo tablet, Placebo gel, Calcium Cardone 500mg with vitamin D 400 IU |
| Enrollment | 44 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2013 |
| Completion | Jan 1, 2015 |
| First posted | Mar 2, 2005 |
| Last update posted | Nov 6, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: